Perspective Therapeutics, Inc.
Status: Publicly traded
Direct answer
Perspective Therapeutics, Inc. is publicly traded on AMEX under the ticker CATX.
Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle – from development and manufacturing to sales and marketing – of radiopharmaceutical products and medical devices. These advanced solutions are designed to treat cancer and other serious malignant conditions, serving markets both within the United States and globally. A flagship product offered by the company...
Can you invest in Perspective Therapeutics, Inc.?
Yes. Perspective Therapeutics, Inc. is publicly traded on AMEX under the ticker CATX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Perspective Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.